NEWS

Virginia Bio Names John Newby CEO

Virginia Bio Names John Newby CEO

Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...

Targeted Nanoparticle Delivery of Paclitaxel

Targeted Nanoparticle Delivery of Paclitaxel

Virginia Tech scientists have developed a cancer drug that increases the effectiveness of a common chemotherapy treatment and dramatically reduces devastating side effects, such as hair loss, nausea, and nerve pain. The new drug uses gold nanoparticles created by the...

Potential drug therapy for radiation exposure

Potential drug therapy for radiation exposure

Potential new treatments for radiation exposure: The investigators exploited an optimized, cell-based,high throughput screening assay to interrogate a small
molecule library comprising 3437 known pharmacologically
active compounds for mitigation against IR-induced...